Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma 31/03/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma.

If you are interested in taking part in a clinical trial, please call us at 935 950 155 and we will assess whether you are eligible. Further information on trials at research projects

Author

Dr. Marc Rosell MD
COMB Medical license number: 51.305
Ophthalmologist
Specialist in Glaucoma